Your browser doesn't support javascript.
loading
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.
Faivre-Finn, Corinne; Snee, Michael; Ashcroft, Linda; Appel, Wiebke; Barlesi, Fabrice; Bhatnagar, Adityanarayan; Bezjak, Andrea; Cardenal, Felipe; Fournel, Pierre; Harden, Susan; Le Pechoux, Cecile; McMenemin, Rhona; Mohammed, Nazia; O'Brien, Mary; Pantarotto, Jason; Surmont, Veerle; Van Meerbeeck, Jan P; Woll, Penella J; Lorigan, Paul; Blackhall, Fiona.
Afiliación
  • Faivre-Finn C; Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: corinne.finn@christie
  • Snee M; St James Institute of Oncology, Leeds, UK.
  • Ashcroft L; Manchester Academic Health Science Centre Trials Co-ordination Unit, The Christie NHS Foundation Trust, Manchester, UK.
  • Appel W; Rosemere Cancer Centre, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
  • Barlesi F; Multidisciplinary Oncology & Therapeutic Innovations Department, Aix Marseille Univ, Assistance Publique Hôpitaux de Marseille, Marseille, France.
  • Bhatnagar A; Department of Clinical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Bezjak A; Canadian Cancer Trials Group, Princess Margaret Cancer Center, Toronto, ON, Canada.
  • Cardenal F; GECP, Department of Medical Oncology, Institut Català'Oncologia, L'Hospitalet (Barcelona), Barcelona, Spain.
  • Fournel P; GFPC, Département d'Oncologie Médicale, Institut de Cancérologie Lucien Neuwirth, Saint-Étienne, France.
  • Harden S; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Le Pechoux C; Département d'Oncologie Radiothérapie, Gustave Roussy Cancer Campus, Villejuif, France.
  • McMenemin R; Northern Centre for Cancer Care, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Mohammed N; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, UK.
  • O'Brien M; Department of Medicine, Royal Marsden NHS Foundation Trust, Surrey, UK.
  • Pantarotto J; Division of Radiation Oncology, University of Ottawa, Ottawa, ON, Canada.
  • Surmont V; Department of Respiratory Medicine/Thoracic Oncology, Ghent University Hospital, Ghent, Belgium.
  • Van Meerbeeck JP; Thoracic Oncology, Antwerp University Hospital, Antwerp, Belgium.
  • Woll PJ; Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK.
  • Lorigan P; Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Blackhall F; Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Lancet Oncol ; 18(8): 1116-1125, 2017 08.
Article en En | MEDLINE | ID: mdl-28642008

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_digestive_diseases / 6_other_blood_disorders / 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_digestive_diseases / 6_other_blood_disorders / 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
...